Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Accumulated Expenses (2016 - 2026)

Trafalgar International (GCAN) posted Accumulated Expenses of $500350.0 for Q1 2026, up 6.38% on a QoQ basis from $470350.0 in Q4 2025, and up 21.93% year-over-year from $410350.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Accumulated Expenses (2016 - 2026) Analysis & Trends

Trafalgar International has reported Accumulated Expenses for 11 years, with the latest figure at $500350.0 in Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 21.93% year-over-year to $500350.0 in Q1 2026; TTM through Mar 2026 was $500350.0, a 21.93% increase from a year earlier, with the FY2025 full-year figure at $470350.0, up 23.66% from the prior year.
  • Accumulated Expenses was $500350.0 for Q1 2026 at Trafalgar International, up from $470350.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $500350.0 in Q1 2026, with the low at $60000.0 in Q2 2025.
  • Average Accumulated Expenses over 5 years is $339653.6, with a median of $340350.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 28524.08% in 2022, then tumbled 81.84% in 2025.
  • Over 5 years, Accumulated Expenses stood at $263000.0 in 2022, then climbed by 29.41% to $340350.0 in 2023, then gained by 11.75% to $380350.0 in 2024, then climbed by 23.66% to $470350.0 in 2025, then gained by 6.38% to $500350.0 in 2026.
  • The last three Accumulated Expenses figures came in at $500350.0 (Q1 2026), $470350.0 (Q4 2025), and $460350.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Trafalgar International 217,335.05 217,335.05 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 500,350.00
Dec 31, 2025 470,350.00
Sep 30, 2025 460,350.00
Jun 30, 2025 60,000.00
Mar 31, 2025 410,350.00
Dec 31, 2024 380,350.00
Sep 30, 2024 350,350.00
Jun 30, 2024 330,350.00
Mar 31, 2024 340,350.00
Dec 31, 2023 340,350.00
Jun 30, 2023 323,000.00
Mar 31, 2023 293,000.00
Dec 31, 2022 263,000.00
Mar 31, 2022 233,000.00
Dec 31, 2021 203,000.00
Sep 30, 2021 203,000.00
Jun 30, 2021 10,613.00
Mar 31, 2021 814.00
Dec 31, 2020 152,000.00
Sep 30, 2020 18,462.00